PubRank
Search
About
Multidisciplinary Study of Right Ventricular Dysplasia
Clinical Trial ID NCT00024505
PubWeight™ 79.39
‹?›
🔗 Visit the ClinicalTrials.gov page for NCT00024505
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria.
Circulation
2010
6.71
2
Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria.
Eur Heart J
2010
4.13
3
Regulatory mutations in transforming growth factor-beta3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1.
Cardiovasc Res
2005
3.99
4
Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Circ Res
2006
2.95
5
Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy.
Am J Hum Genet
2002
2.95
6
Arrhythmogenic right ventricular dysplasia: a United States experience.
Circulation
2005
2.94
7
Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.
Circulation
2006
2.81
8
Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2.
Circulation
2006
2.69
9
Echocardiographic findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia: new insights from the multidisciplinary study of right ventricular dysplasia.
J Am Coll Cardiol
2005
2.62
10
Misdiagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
J Cardiovasc Electrophysiol
2004
2.59
11
Noninvasive detection of myocardial fibrosis in arrhythmogenic right ventricular cardiomyopathy using delayed-enhancement magnetic resonance imaging.
J Am Coll Cardiol
2005
2.30
12
Normal reference values for the adult right ventricle by magnetic resonance imaging.
Am J Cardiol
2006
2.13
13
Magnetic resonance imaging findings in patients meeting task force criteria for arrhythmogenic right ventricular dysplasia.
J Cardiovasc Electrophysiol
2003
1.99
14
Role of magnetic resonance imaging in arrhythmogenic right ventricular dysplasia: insights from the North American arrhythmogenic right ventricular dysplasia (ARVD/C) study.
Am Heart J
2007
1.86
15
DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Am J Hum Genet
2006
1.85
16
The detection of cardiotropic viruses in the myocardium of patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
J Am Coll Cardiol
2002
1.66
17
Quantitative assessment of angiographic right ventricular wall motion in arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C).
J Cardiovasc Electrophysiol
2007
1.65
18
Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy.
Eur Heart J
2015
1.62
19
Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia: sensitivity, specificity, and observer variability of fat detection versus functional analysis of the right ventricle.
J Am Coll Cardiol
2006
1.55
20
Penetrance of mutations in plakophilin-2 among families with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
J Am Coll Cardiol
2006
1.46
21
Role of cardiovascular magnetic resonance imaging in arrhythmogenic right ventricular dysplasia.
J Cardiovasc Magn Reson
2008
1.45
22
Implantable cardioverter-defibrillators in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
J Am Coll Cardiol
2004
1.37
23
Long-term efficacy of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy.
J Am Coll Cardiol
2007
1.37
24
Arrhythmogenic right ventricular cardiomyopathy causing sudden cardiac death in boxer dogs: a new animal model of human disease.
Circulation
2004
1.33
25
Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C): a multidisciplinary study: design and protocol.
Circulation
2003
1.32
26
Prevalence of T-wave inversion beyond V1 in young normal individuals and usefulness for the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia.
Am J Cardiol
2005
1.29
27
Differentiating arrhythmogenic right ventricular cardiomyopathy from right ventricular outflow tract ventricular tachycardia using multilead QRS duration and axis.
Heart Rhythm
2006
1.22
28
MRI of arrhythmogenic right ventricular cardiomyopathy/dysplasia.
J Cardiovasc Magn Reson
2004
1.13
29
Do patients with right ventricular outflow tract ventricular arrhythmias have a normal right ventricular wall motion? A quantitative analysis compared to normal subjects.
Cardiology
2005
1.07
30
Right ventricle shape and contraction patterns and relation to magnetic resonance imaging findings.
J Comput Assist Tomogr
2005
1.02
31
Predictors of appropriate implantable defibrillator therapies in patients with arrhythmogenic right ventricular dysplasia.
Heart Rhythm
2005
1.01
32
Evaluation of the normal values for signal-averaged electrocardiogram.
J Cardiovasc Electrophysiol
2007
1.01
33
Feasibility and variability of three dimensional echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Am J Cardiol
2006
1.00
34
Arrhythmogenic right ventricular cardiomyopathy: a 'final common pathway' that defines clinical phenotype.
Eur Heart J
2007
1.00
35
Magnetic resonance and computed tomography imaging of arrhythmogenic right ventricular dysplasia.
J Magn Reson Imaging
2004
0.99
36
Comparison of novel echocardiographic parameters of right ventricular function with ejection fraction by cardiac magnetic resonance.
J Am Soc Echocardiogr
2007
0.97
37
Arrhythmogenic right ventricular dysplasia: ex vivo and in vivo fat detection with black-blood MR imaging.
Radiology
2004
0.95
38
Findings on magnetic resonance imaging of idiopathic right ventricular outflow tachycardia.
Am J Cardiol
2004
0.94
39
Evolving role of multidetector computed tomography in evaluation of arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Am J Cardiol
2007
0.89
40
The mystery of arrhythmogenic right ventricular dysplasia/cardiomyopathy: from observation to mechanistic explanation.
Circulation
2006
0.88
41
TAIL1: an isthmin-like gene, containing type 1 thrombospondin-repeat and AMOP domain, mapped to ARVD1 critical region.
Gene
2004
0.87
42
Arrhythmogenic right ventricular cardiomyopathy type 1 (ARVD1): confirmation of locus assignment and mutation screening of four candidate genes.
Eur J Hum Genet
2003
0.85
43
Utility of tissue Doppler and strain echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Am J Cardiol
2007
0.84
44
Magnetic resonance imaging of arrhythmogenic right ventricular dysplasia.
J Cardiovasc Electrophysiol
2002
0.83
45
A woman with incidental findings of ventricular aneurysms and a desmosomal cardiomyopathy.
Heart Rhythm
2008
0.80
46
Filtered QRS duration on signal-averaged electrocardiography predicts inducibility of ventricular tachycardia in arrhythmogenic right ventricle dysplasia.
Pacing Clin Electrophysiol
2003
0.80
47
Regional differences in systolic and diastolic function in arrhythmogenic right ventricular dysplasia/cardiomyopathy using magnetic resonance imaging.
Am J Cardiol
2005
0.80
48
Interleaved acquisition of lipid and water images of the heart using a double-inversion fast spin-echo method.
Magn Reson Med
2005
0.79
49
Utility of SAECG in arrhythmogenic right ventricle dysplasia.
Ann Noninvasive Electrocardiol
2003
0.78
50
Arrhythmogenic right ventricular dysplasia/cardiomyopathy.
Circulation
2003
0.77
51
Echocardiographic findings and the search for a gold standard in patients with arrhythmogenic right ventricular dysplasia.
J Am Coll Cardiol
2005
0.75
Next 100